BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26095521)

  • 21. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
    Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
    Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness.
    Wang RY; Braunlin EA; Rudser KD; Dengel DR; Metzig AM; Covault KK; Polgreen LE; Shapiro E; Steinberger J; Kelly AS
    Mol Genet Metab; 2014 Feb; 111(2):128-32. PubMed ID: 24268528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
    Eisengart JB; Rudser KD; Xue Y; Orchard P; Miller W; Lund T; Van der Ploeg A; Mercer J; Jones S; Mengel KE; Gökce S; Guffon N; Giugliani R; de Souza CFM; Shapiro EG; Whitley CB
    Genet Med; 2018 Nov; 20(11):1423-1429. PubMed ID: 29517765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
    Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
    Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early disease progression of Hurler syndrome.
    Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
    Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPS I: Early diagnosis, bone disease and treatment, where are we now?
    Kingma SDK; Jonckheere AI
    J Inherit Metab Dis; 2021 Nov; 44(6):1289-1310. PubMed ID: 34480380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
    Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
    J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.
    Giugliani R; Muschol N; Keenan HA; Dant M; Muenzer J
    Arch Dis Child; 2021 Jul; 106(7):674-679. PubMed ID: 33139350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.
    Pillai NR; Elsbecker SA; Gupta AO; Lund TC; Orchard PJ; Braunlin E
    Mol Genet Metab; 2023 Nov; 140(3):107669. PubMed ID: 37542767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The development of cognitive functions in children with Hurler phenotype mucopolysaccharidosis type I on enzyme replacement therapy with laronidase].
    Biernacka M; Jakubowska-Winecka A; Tylki-Szymańska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):249-54. PubMed ID: 21447265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.
    Koehne T; Müller-Stöver S; Köhn A; Stumpfe K; Lezius S; Schmid C; Lukacs Z; Kahl-Nieke B; Muschol N
    Sleep Breath; 2019 Dec; 23(4):1315-1321. PubMed ID: 31332621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation.
    Polgreen LE; Tolar J; Plog M; Himes JH; Orchard PJ; Whitley CB; Miller BS; Petryk A
    Bone Marrow Transplant; 2008 Jun; 41(12):1005-11. PubMed ID: 18278070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
    Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
    Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome.
    Eisengart JB; Rudser KD; Tolar J; Orchard PJ; Kivisto T; Ziegler RS; Whitley CB; Shapiro EG
    J Pediatr; 2013 Feb; 162(2):375-80.e1. PubMed ID: 22974573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
    D'Aco K; Underhill L; Rangachari L; Arn P; Cox GF; Giugliani R; Okuyama T; Wijburg F; Kaplan P
    Eur J Pediatr; 2012 Jun; 171(6):911-9. PubMed ID: 22234477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.